• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cosmos Health Inc. - Common Stock (NQ:COSM)

0.3313 -0.0051 (-1.52%)
Delayed Quote Updated: 4:00 PM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cosmos Health Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
News headline image
Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares Valued at $526,000 Over the Past Week; 2,777,469 Shares Acquired Over the Past Five Months for $1,325,000
April 30, 2025
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million
April 16, 2025
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract Manufacturing Agreement with Pharmex for 1.5 Million Bottles of the Antiseptic Drug AMBITASOL 1L
April 09, 2025
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Announces Launch Of Food Supplement Brand In Albania: Retail Sentiment Improves ↗
April 08, 2025
The company said that the launch is in partnership with Tirana-based pharmaceutical company Pharma Cell, which will serve as the distributor in the country. 
Via Stocktwits
Topics Economy Government
News headline image
Cosmos Health Launches Sky Premium Life in Albania through Partnership with Pharma Cell; Secures Initial $300,000 Order
April 08, 2025
From Cosmos Health Inc.
Via GlobeNewswire
News headline image
Cosmos Health Expands Sky Premium Life Nutraceuticals Brand with 60 New SKUs as Global Growth Accelerates
February 26, 2025
Via ACCESS Newswire
News headline image
EXCLUSIVE: Virax Biolabs Says Its Tech Fits RFK Jr.'s HHS Goals On Vaccine Transparency ↗
February 25, 2025
Virax Biolabs supports HHS's focus on vaccine efficacy transparency, offering technology to assess immune responses and collaborate with developers to improve vaccine research. 
Via Benzinga
News headline image
Cosmos Health Announces It will not Proceed with an Offering Under Its Form S-1
February 18, 2025
Via ACCESS Newswire
News headline image
Cosmos Health Enters Final Development Phase of CCX0722 Weight Management Solution; Expected Product Launch in Q1 or Q2 2026, Gaining Access to Over $142 Billion Market
February 11, 2025
Via ACCESS Newswire
News headline image
Cosmos Health Advances Cancer Treatment Innovation with Two New AI-Driven Patent Filings for Gliomas and Hematologic Malignancies; $25 Billion+ Global Market
February 10, 2025
Via ACCESS Newswire
News headline image
Cosmos Health Strengthens Management Team with the Appointment of Veteran Executive Dimitris Moraitis as Vice President of Strategy & Operations
February 10, 2025
Via ACCESS Newswire
News headline image
Cosmos Health Pockets 10-Year Manufacturing Deal With Provident Pharmaceuticals ↗
February 07, 2025
Cosmos Health announced a ten-year contract with Provident Pharmaceuticals for production of four key drugs. 
Via Benzinga
News headline image
Cosmos Health Secures 10-Year Long-Term Contract Manufacturing Order from Provident Pharmaceuticals for 4 Additional Products, Totaling 8 Million Packs, Significantly Expanding High-Margin Revenue Backlog and Cash Flow Visibility
February 07, 2025
Via ACCESS Newswire
News headline image
Cosmos Health Receives $578,460 Initial Purchase Order from Al Rabwa International for Sky Premium Life Food Supplements in Qatar
February 06, 2025
Via ACCESS Newswire
News headline image
Cosmos Health Files New AI-Driven Patent Application for Multiple Sclerosis Treatment, Targeting $25 Billion+ Global Market
February 05, 2025
Via ACCESS Newswire
News headline image
Cosmos Health Secures Bond Loan from European Bank on Very Competitive Terms, with Option to Upsize to Support Growth and Achieve Positive Operating Cash Flow
January 28, 2025
Via ACCESS Newswire
News headline image
Cosmos Health Submits Patent Application for Allergic Inflammation Therapy by Leveraging AI Drug Repurposing; Allergy Treatment Market Valued at $23.5 Billion
January 27, 2025
Via ACCESS Newswire
News headline image
Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait
January 23, 2025
Via ACCESS Newswire
News headline image
Cosmos Health Secures Two WIPO-Patented Anticancer Drugs for Prostate, Ovarian, and Colorectal Cancers, Valued at Over $24.5 Million
January 22, 2025
Via ACCESS Newswire
News headline image
Cosmos Health CEO Greg Siokas Acquires a Total of 647,809 Shares Valued at $425,000 Over the Past 32 Days
January 21, 2025
Via ACCESS Newswire
News headline image
Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries
January 13, 2025
Via ACCESSWIRE
News headline image
Cosmos Health Strengthens R&D Leadership and Innovation with the Appointment of Professor Dimitrios Trafalis, MD, as Head of Oncology
December 26, 2024
Via ACCESSWIRE
News headline image
Cosmos Health CEO Greg Siokas and CFO George Terzis Collectively Increase Stake by 343,000 Shares Valued at $200,000
December 23, 2024
Via ACCESSWIRE
News headline image
Taglich Brothers Releases Updated Coverage on Cosmos Health: Projects Positive EPS for 2025 and Sets $3 Price Target, Nearly 300% Above Current Share Price
November 26, 2024
Via ACCESSWIRE
News headline image
Cosmos Health Integrates Bitcoin and Ethereum as Treasury Reserve Assets
November 18, 2024
Via ACCESSWIRE
News headline image
Cosmos Health Reports Q3 2024 Results: Resilient Revenue and Gross Profit Amid 18.6% Expense Reduction; Stockholders' Equity Up 8.8% to $35M QoQ
November 14, 2024
Via ACCESSWIRE
News headline image
Cosmos Health Issues Letter to Shareholders
November 12, 2024
Via ACCESSWIRE
News headline image
Cosmos Health’s Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, with Gross Profit Rising 21%
November 01, 2024
Via ACCESSWIRE
News headline image
How Cosmos Health’s Acquisition Of Almost 100-Year-Old Company, Adding To Capabilities Like Contract Manufacturing, Could Generate Over $10 Million In Annual Gross Profit
October 01, 2024
How Cosmos Health’s Acquisition Of Almost 100-Year-Old Company, Adding To Capabilities Like Contract Manufacturing, Could Generate Over $10 Million In Annual Gross Profit 
Via News Direct
News headline image
Cosmos Health Reports Strong 160% Increase in 2024 YTD Sales on Amazon UK for Its Proprietary Brands
September 25, 2024
Via ACCESSWIRE
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap